These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 17623614)
1. Role of radioactive iodine for adjuvant therapy and treatment of metastases. Jonklaas J J Natl Compr Canc Netw; 2007 Jul; 5(6):631-40. PubMed ID: 17623614 [TBL] [Abstract][Full Text] [Related]
2. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Jarzab B; Handkiewicz-Junak D; Wloch J Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322 [TBL] [Abstract][Full Text] [Related]
3. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer. Padma S; Sundaram PS J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519 [TBL] [Abstract][Full Text] [Related]
4. Radioiodine treatment for malignant thyroid disease. Berg G Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836 [TBL] [Abstract][Full Text] [Related]
6. [The basis for radioiodine therapy in differentiated thyroid cancer]. Haldemann AR Ther Umsch; 1999 Jul; 56(7):403-7. PubMed ID: 10434780 [TBL] [Abstract][Full Text] [Related]
7. Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer. Zhang L; Li Z; Zhang M; Zou H; Bai Y; Liu Y; Lv J; Lv L; Liu P; Deng Z; Liu C Med Oncol; 2023 Jul; 40(9):258. PubMed ID: 37524925 [TBL] [Abstract][Full Text] [Related]
8. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662 [TBL] [Abstract][Full Text] [Related]
9. [Indications for adjuvant therapy of thyroid cancer with radioiodine therapy]. Jarzab B Wiad Lek; 2001; 54 Suppl 1():254-65. PubMed ID: 12182034 [TBL] [Abstract][Full Text] [Related]
10. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma. Robbins RJ; Schlumberger MJ J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649 [TBL] [Abstract][Full Text] [Related]
12. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome. Logue JP; Tsang RW; Brierley JD; Simpson WJ Br J Radiol; 1994 Nov; 67(803):1127-31. PubMed ID: 7820407 [TBL] [Abstract][Full Text] [Related]
13. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells. Xu S; Cheng X; Wu J; Wang Y; Wang X; Wu L; Yu H; Bao J; Zhang L J Mol Cell Biol; 2022 Jan; 13(11):791-807. PubMed ID: 34751390 [TBL] [Abstract][Full Text] [Related]
14. Curcumin enhances the membrane trafficking of the sodium iodide symporter and augments radioiodine uptake in dedifferentiated thyroid cancer cells Zhang L; Xu S; Cheng X; Wu J; Wang X; Wu L; Yu H; Bao J Food Funct; 2021 Sep; 12(18):8260-8273. PubMed ID: 34323243 [TBL] [Abstract][Full Text] [Related]
15. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Fard-Esfahani A; Emami-Ardekani A; Fallahi B; Fard-Esfahani P; Beiki D; Hassanzadeh-Rad A; Eftekhari M Nucl Med Commun; 2014 Aug; 35(8):808-17. PubMed ID: 24751702 [TBL] [Abstract][Full Text] [Related]
16. Initial radioiodine administration: when to use it and how to select the dose. Esposito G Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168 [TBL] [Abstract][Full Text] [Related]
17. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962 [TBL] [Abstract][Full Text] [Related]
18. [β-catenin nuclear translocation represses thyroid cancer stem cells differentiating into cells with sodium-iodine symporter functional expression]. Lan L; Deng W; Cui D; Chen HL; Huo LL; Zuo QY; Li W; Zhang GY; Luo Y Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1904-1910. PubMed ID: 31269588 [No Abstract] [Full Text] [Related]
19. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638 [TBL] [Abstract][Full Text] [Related]
20. Salivary gland malignancy and radioiodine therapy for thyroid cancer. Klubo-Gwiezdzinska J; Van Nostrand D; Burman KD; Vasko V; Chia S; Deng T; Kulkarni K; Wartofsky L Thyroid; 2010 Jun; 20(6):647-51. PubMed ID: 20470209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]